Literature DB >> 30013664

Clinicopathological characteristics of malignant melanomas of the skin and gastrointestinal tract.

Michiko Akiyama1,2, Yoko Matsuda2, Tomio Arai2, Hidehisa Saeki1.   

Abstract

The present study examined the differences between gastrointestinal melanoma (GM) and skin melanoma (SM). The clinicopathological characteristics, the expression of melanoma stem cell markers nestin, sex determining region Y-box 2 and ATP-binding cassette sub-family B member 5, and the presence of the BRAFV600E mutation were evaluated in 10 cases of GM and 31 cases of SM. Patients with GM had an increased mean age compared with those with SM (76 vs. 68 years). In addition, GMs were significantly more likely than SMs to be amelanotic (50 vs. 7%; P=0.001) and display round cells (70 vs. 23%; P=0.02). The mitosis rate was also significantly higher in GM compared with SM (P<0.05). The incidence of lymph-node metastasis (60 vs. 32%; P<0.05) and distant metastasis (10 vs. 6.5%, P=0.02) was significantly higher in GMs compared with SMs. The expression of stem cell markers did not differ significantly between groups, however, in the SM group advanced-stage disease was associated with a significantly higher expression of nestin than early-stage disease (P<0.05). Immunohistochemically, the expression of BRAFV600E was significantly lower in GMs compared with in SMs (1.0 vs. 3.3; P=0.01). These findings indicate that the identification of these features may aid in the diagnosis of GM and SM, as well as contribute to the development of novel targeted therapies against GM.

Entities:  

Keywords:  BRAFV600E; gastrointestinal melanoma; malignant melanoma; mitosis; nestin; stem cell marker

Year:  2018        PMID: 30013664      PMCID: PMC6036557          DOI: 10.3892/ol.2018.8913

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  39 in total

1.  Distinct sets of genetic alterations in melanoma.

Authors:  John A Curtin; Jane Fridlyand; Toshiro Kageshita; Hetal N Patel; Klaus J Busam; Heinz Kutzner; Kwang-Hyun Cho; Setsuya Aiba; Eva-Bettina Bröcker; Philip E LeBoit; Dan Pinkel; Boris C Bastian
Journal:  N Engl J Med       Date:  2005-11-17       Impact factor: 91.245

2.  Identification of recurrent mutational events in anorectal melanoma.

Authors:  Hui Min Yang; Susan J Hsiao; David F Schaeffer; Chi Lai; Helen E Remotti; David Horst; Mahesh M Mansukhani; Basil A Horst
Journal:  Mod Pathol       Date:  2016-10-14       Impact factor: 7.842

Review 3.  Cancer Stem Cells (CSCs) in melanoma: There's smoke, but is there fire?

Authors:  Constance E Brinckerhoff
Journal:  J Cell Physiol       Date:  2017-03-06       Impact factor: 6.384

4.  Increased expression of stem cell markers in malignant melanoma.

Authors:  Walter M Klein; Bryan P Wu; Shuping Zhao; Hong Wu; Andres J P Klein-Szanto; Steven R Tahan
Journal:  Mod Pathol       Date:  2006-11-24       Impact factor: 7.842

5.  Profiling of ABC transporters ABCB5, ABCF2 and nestin-positive stem cells in nevi, in situ and invasive melanoma.

Authors:  Namrata Setia; Ossama Abbas; Yessica Sousa; Jane L Garb; Meera Mahalingam
Journal:  Mod Pathol       Date:  2012-05-04       Impact factor: 7.842

6.  Model predicting survival in stage I melanoma based on tumor progression.

Authors:  W H Clark; D E Elder; D Guerry; L E Braitman; B J Trock; D Schultz; M Synnestvedt; A C Halpern
Journal:  J Natl Cancer Inst       Date:  1989-12-20       Impact factor: 13.506

7.  Identification of cells initiating human melanomas.

Authors:  Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

Review 9.  Mucosal melanomas in the elderly: challenging cases and review of the literature.

Authors:  Flavia Baderca; Dana Vincze; Nicolae Balica; Caius Solovan
Journal:  Clin Interv Aging       Date:  2014-06-12       Impact factor: 4.458

10.  Incidence, Surgical Treatment, and Prognosis of Anorectal Melanoma From 1973 to 2011: A Population-Based SEER Analysis.

Authors:  Haiyan Chen; Yibo Cai; Yue Liu; Jinjie He; Yeting Hu; Qian Xiao; Wangxiong Hu; Kefeng Ding
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more
  4 in total

Review 1.  Evolving Treatment Approaches to Mucosal Melanoma.

Authors:  Shuai Zhang; Jiaran Zhang; Jun Guo; Lu Si; Xue Bai
Journal:  Curr Oncol Rep       Date:  2022-05-05       Impact factor: 5.945

2.  PD-L1 expression in malignant melanomas of the skin and gastrointestinal tract.

Authors:  Michiko Akiyama; Yoko Matsuda; Tomio Arai; Hidehisa Saeki
Journal:  Oncol Lett       Date:  2020-01-21       Impact factor: 2.967

Review 3.  Immunotherapy in Acral and Mucosal Melanoma: Current Status and Future Directions.

Authors:  Lili Mao; Zhonghui Qi; Li Zhang; Jun Guo; Lu Si
Journal:  Front Immunol       Date:  2021-06-04       Impact factor: 7.561

4.  Surgical Outcomes of Vaginal or Cervical Melanoma.

Authors:  Hui Tian; Xuan Wang; Bin Lian; Lu Si; Min Gao; Hong Zheng; Zhihong Chi; Yan Kong; Lili Mao; Xue Bai; Bixia Tang; Xieqiao Yan; Siming Li; Li Zhou; Jie Dai; Yangchun Sun; Lingying Wu; Jun Guo; Chuanliang Cui
Journal:  Front Surg       Date:  2022-01-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.